News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • Drugs that inhibit CDK7 may be a new therapy for treating triple-negative breast cancer.

Tags: BreastCancer

  • In the first ever randomized trial in the United States, researchers led by Dr. Wendy Chen will test whether aspirin helps women with breast cancer avoid recurrence and live longer.

Tags: BreastCancer

  • Tari King, MD, has been named Chief of Breast Surgery at Dana-Farber/Brigham and Women's Cancer Center where she will oversee breast surgery and continue to build DF/BWCC's integrated clinical model for treating breast cancer.

Tags: BreastCancer

  • Study led by Dr. Jennifer Ligibel finds exercise programs can improve quality of life for cancer survivors.

Tags: BreastCancer, Nutrition

  • Researchers from Dana-Farber Cancer Institute will be presenting more than 70 studies at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 29 – June 2, 2015.

Tags: chemotherapy, BreastCancer

  • A new iPhone app launched by Apple today will provide physician researchers with instant data from breast cancer survivors with a goal of providing patients improved post-treatment quality of life.

Tags: BreastCancer, Survivorship

  • A study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug olaparib is potentially much wider — and offers a ready means of identifying them.

Tags: BreastCancer, OvarianCancer

  • A new study finds many breast cancer patients don't know the characteristics of their own disease, such as cancer stage and tumor grade.

Tags: BreastCancer, PatientEducation

  • Dana-Farber researchers report women with small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years.

Tags: BreastCancer, TargetedTherapy

  • In a clinical trial involving women with triple-negative breast cancer, patients who received the drugs carboplatin and/or bevacizumab in combination with standard chemotherapy prior to surgery were more likely to have their tumors disappear entirely from the breast, according to data presented by investigators during the 2014 San Antonio Breast Cancer Symposium.

Tags: BreastCancer

Showing 1-10 of 59 items